Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug

By: via Business Journals
A Plymouth Meeting firm may seek an additional regulatory approval for its sleep disorder medicine.
Related Stocks:
Harbor Disruptive Innovation ETF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.